2006
DOI: 10.1590/s0004-27492006000300026
|View full text |Cite
|
Sign up to set email alerts
|

Linfoma de células da zona do manto em anexos oculares: relato de caso

Abstract: Descritores: Linfoma de células do manto; Linfoma não-Hodgkin; Linfoma de células B; Antineoplásicos; Idoso; Relatos de casos [Tipo de publicação] INTRODUÇÃOAs lesões linfóides orbitais representam 10% de todos os tumores orbitais primários, enquanto os anexos orbitais podem ser envolvidos em cerca de 1,5% dos pacientes com linfoma não-Hodgkin sistêmico (1)(2) . É estimado ainda, que os linfomas dos anexos oculares representam aproximadamente 8% dos linfomas não-Hodgkin (3) . Os tumores linfóides dos anexo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0
1

Year Published

2008
2008
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 15 publications
0
3
0
1
Order By: Relevance
“…Our report shows how mantle cell OALs can be successfully treated with localized radiation therapy, em- Coupland et al 8 2 NR IE-IIE Orbit/Lid CT-RT 10-year OS: 70-90% Auw-Haedrich et al 9 2 1 P; 1 S I-III Conjunctiva/Lid CT-RT Persistent tumor Jenkins et al 12 6 1 P; 5 S IV NR CT-RT 1/6 LRD Lemos et al 16 1 P IV Lid CVP-HyperCVAD-ASCT CR after therapy Looi et al 18 10 8 P; 2 S IE-IV Orbit/LG/Lid CHOP-Chl-Pr 5-year PFS/OS: 0%-39% Hon et al 19 8 2 P; 6 S IIAE-IV Orbit/Lid/Conjunctiva CT-RT-BMT ST 22-192 months Esmaeli et al 20 2 2 S III-IV Orbit RT-Rit-ESHAP 1 PR; 1 SD Fung et al 10 7 3 P; 4 S IV NR CT-RT NR Sharara et al 21 3 NR II Orbit/LG NR Concurrent sd Cahill et al 11 1 S NR Conjunctiva CHOP Died of S lymphoma Nola et al 22 1 NR NR NR NR NR Bhatia et al 23 6 6 P IAE NR RT NR Zhou et al 24 6 3 P; 3 S NR NR NR NR McKelvie et al 25 2 1 P; 1S IIE-IV Orbit/LG RT-CT LRD 30 mo. after therapy Le et al 26 2 NR NR NR NR NR Ahmed et al 27 1 P IV Orbit CHOP-RT NR P, primary; S, secondary; RT, radiotherapy; CT, chemotherapy; CHOP, cyclophosphamide, vincristine, adriamycin, prednisone; CVP, cyclophosphamide, vincristine, prednisone;…”
Section: Discussionmentioning
confidence: 63%
See 1 more Smart Citation
“…Our report shows how mantle cell OALs can be successfully treated with localized radiation therapy, em- Coupland et al 8 2 NR IE-IIE Orbit/Lid CT-RT 10-year OS: 70-90% Auw-Haedrich et al 9 2 1 P; 1 S I-III Conjunctiva/Lid CT-RT Persistent tumor Jenkins et al 12 6 1 P; 5 S IV NR CT-RT 1/6 LRD Lemos et al 16 1 P IV Lid CVP-HyperCVAD-ASCT CR after therapy Looi et al 18 10 8 P; 2 S IE-IV Orbit/LG/Lid CHOP-Chl-Pr 5-year PFS/OS: 0%-39% Hon et al 19 8 2 P; 6 S IIAE-IV Orbit/Lid/Conjunctiva CT-RT-BMT ST 22-192 months Esmaeli et al 20 2 2 S III-IV Orbit RT-Rit-ESHAP 1 PR; 1 SD Fung et al 10 7 3 P; 4 S IV NR CT-RT NR Sharara et al 21 3 NR II Orbit/LG NR Concurrent sd Cahill et al 11 1 S NR Conjunctiva CHOP Died of S lymphoma Nola et al 22 1 NR NR NR NR NR Bhatia et al 23 6 6 P IAE NR RT NR Zhou et al 24 6 3 P; 3 S NR NR NR NR McKelvie et al 25 2 1 P; 1S IIE-IV Orbit/LG RT-CT LRD 30 mo. after therapy Le et al 26 2 NR NR NR NR NR Ahmed et al 27 1 P IV Orbit CHOP-RT NR P, primary; S, secondary; RT, radiotherapy; CT, chemotherapy; CHOP, cyclophosphamide, vincristine, adriamycin, prednisone; CVP, cyclophosphamide, vincristine, prednisone;…”
Section: Discussionmentioning
confidence: 63%
“…While MALT-NHLs represent the commonest lymphoma type affecting the ocular adnexa, MCL has also been described within large series of OALs and in anecdotal reports 16 (Table 1). One recent detailed clinicalpathological study collected and analyzed 353 cases of OAL diagnosed at the Massachusetts General Hospital between 1974 and 2005: 19 patients were affected by ocular adnexal MCL; 12 of them (63%) had a previous history of lymphoma, while 4 of 7 patients presented with ocular adnexal involvement in the setting of widespread lymphoproliferative disease 17 .…”
Section: Discussionmentioning
confidence: 99%
“…We also summarized 48 patients with MCL in the literature who presented with ocular adnexal lesions in order to elucidate their clinical features. 33 - 77 …”
Section: Introductionmentioning
confidence: 99%
“…A órbita é um sítio raro dessa doença, estimando-se que nela ocorra apenas 1 a 8% dos LNH (1)(2)(3)(4)(5) . Apesar dos linfomas representarem aproximadamente 10% de todos os tumores primários da órbita, o acometimento orbitário por linfoma sistêmico ocorre em apenas 1,5% dos casos (2) . O caso aqui apresentado é de um portador de LNH sistêmico com acometimento orbitário bilateral, em que o diagnóstico da neoplasia foi feito a partir de sinais e sintomas oculares.…”
unclassified